SFDA Launches NADR Program for Rare Disease Drug Development
Riyadh: The Saudi Food and Drug Authority (SFDA) has launched the New Accelerator Program for Drugs in Rare Diseases (NADR), a specialized regulatory initiative designed to support the development of and access to medicines for rare diseases, empower …